tiprankstipranks
Trending News
More News >
NovaBridge Biosciences (NBP)
NASDAQ:NBP
US Market

NovaBridge Biosciences (NBP) Financial Statements

Compare
425 Followers

NovaBridge Biosciences Financial Overview

NovaBridge Biosciences's market cap is currently $421.97M. The company's EPS TTM is $-0.03; its P/E ratio is -5.24; NovaBridge Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 0.00¥ 4.49M¥ -10.70M¥ 88.03M¥ 1.54B
Gross Profit¥ 0.00¥ 4.49M¥ -248.80M¥ 41.59M¥ 1.54B
Operating Income¥ -375.36M¥ -511.16M¥ -366.08M¥ -2.07B¥ 155.57M
EBITDA¥ -373.45M¥ -344.25M¥ -51.23M¥ -2.06B¥ 168.31M
Net Income¥ -162.26M¥ -1.47B¥ -2.51B¥ -2.33B¥ 470.92M
Balance Sheet
Cash & Short-Term Investments¥ 173.40M¥ 2.29B¥ 3.45B¥ 670.96M¥ 733.21M
Total Assets¥ 212.68M¥ 2.61B¥ 4.07B¥ 5.63B¥ 6.33B
Total Debt¥ 3.88M¥ 133.87M¥ 38.29M¥ 112.45M¥ 13.60M
Net Debt¥ -64.38M¥ -2.01B¥ -3.18B¥ -3.41B¥ -4.75B
Total Liabilities¥ 11.52M¥ 894.81M¥ 1.07B¥ 1.04B¥ 706.65M
Stockholders' Equity¥ 201.16M¥ 1.72B¥ 3.01B¥ 4.59B¥ 5.63B
Cash Flow
Free Cash Flow¥ -52.72M¥ -73.02M¥ -1.15B¥ -1.00B¥ 425.55M
Operating Cash Flow¥ -52.67M¥ -72.85M¥ -1.10B¥ -973.09M¥ 433.56M
Investing Cash Flow¥ -135.97M¥ -107.63M¥ 458.38M¥ -727.21M¥ -201.90M
Financing Cash Flow-¥ -8.25M¥ 42.36M¥ 593.92M¥ 3.44B
Currency in CNY

NovaBridge Biosciences Earnings and Revenue History

NovaBridge Biosciences Debt to Assets

NovaBridge Biosciences Cash Flow

NovaBridge Biosciences Forecast EPS vs Actual EPS